Abaloparatide TFA

阿巴洛帕肽 TFA

Abaloparatide TFA

A658609-5mg

5mg

≥96%

避光,充氩,干燥,-80℃储存

超低温冰袋运输

Abaloparatide TFA (BA 058 TFA) is a parathyroid hormone receptor 1 (PTHR1) analogue. Abaloparatide TFA also is a selective PTHR1 activator. Abaloparatide TFA enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide TFA enhances bone formation Appearance:Solid IC50& Target:Parathyroid hormone receptor 1 (PTHR1) In Vitro:Abaloparatide TFA (0-100 nM; 40 min) enhances Gs/cAMP signaling and β-arrestin recruitment in MC3T3-E1 cells. Abaloparatide TFA (0-100 nM) efficiently induces PTHR1 internalization in a dose-dependen manner with an EC 50 value of 0.8 nM in U2OS Cell In Vivo:Abaloparatide TFA (20-80 µg/kg; s.c.; daily for 30 days) enhances bone formation and cortical structure in mouse. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female Sprague-Dawley rats Biological Activity:Abaloparatide TFA (BA 058 TFA) is a parathyroid hormone receptor 1 (PTHR1) analogue. Abaloparatide TFA also is a selective PTHR1 activator. Abaloparatide TFA enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide TFA enhances bone formation

C176H301N56F3O51

4074.61 g/mol

H2O : ≥ 50 mg/mL (12.27 mM)